keyword
https://read.qxmd.com/read/38642261/basal-insulinotherapy-in-patients-living-with-diabetes-in-france-the-ef-bi-study
#21
JOURNAL ARTICLE
Pierre Gourdy, Patrice Darmon, Isabelle Borget, Corinne Emery, Isabelle Bureau, Bruno Detournay, Amar Bahloul, Noemie Allali, Aymeric Mahieu, Alfred Penfornis
INTRODUCTION: Second-generation basal insulins like glargine 300 U/mL (Gla-300) have a longer duration of action and less daily fluctuation and interday variability than first-generation ones, such as glargine 100 U/mL (Gla-100). The EF-BI study, a nationwide observational, retrospective study, was designed to compare persistence, acute care complications, and healthcare costs associated with the initiation of such basal insulins (BI) in a real-life setting in France. METHODS: This study was conducted using the French healthcare claims database (SNDS)...
April 20, 2024: Diabetes Therapy: Research, Treatment and Education of Diabetes and related Disorders
https://read.qxmd.com/read/38642260/real-world-effectiveness-of-the-gla-300%C3%A2-%C3%A2-cap%C3%A2-%C3%A2-app-program-in-adult-users-living-with-type%C3%A2-2-diabetes-in-taiwan
#22
JOURNAL ARTICLE
Chih-Yuan Wang, Fang L Zhou, Aakash B Gandhi, Tsung-Ying Lee, Nancy Cui, Jiuo-Shan Mao, Jung-Fu Chen
INTRODUCTION: Health2Sync (H2S) is a digital health technology platform that provides coaching and titration support to patients with diabetes. The Mallya cap converts a conventional insulin pen into a smart connected device that can automatically synchronize dose values and associated timestamps (upon injection) to the H2S platform. This single-arm real-world study evaluated the effectiveness of insulin glargine 300 U/mL (Gla-300) combined with H2S and Mallya cap (Gla-300 + Cap + App program) on clinical outcomes among users with type 2 diabetes (T2D) in Taiwan...
April 20, 2024: Diabetes Therapy: Research, Treatment and Education of Diabetes and related Disorders
https://read.qxmd.com/read/38642046/the-impact-of-behavioral-lifestyle-intervention-on-inflammatory-cytokines-in-older-adults-living-with-type-2-diabetes-a-feasibility-study
#23
JOURNAL ARTICLE
Rozmin Jiwani, Monica Serra, Sara Espinoza, Andrea Berndt, Darpan Patel
OBJECTIVE: This study investigates the effects of a behavioral lifestyle intervention on inflammatory cytokines and frailty in older adults (≥ 65 years) with type 2 diabetes (T2D). METHOD: We conducted a single-arm, 6-month intervention supplemented with diet and activity self-monitoring technology. We assessed frailty using Fried criteria and quantified inflammatory cytokines (interleukin [IL]-2, IL-4, IL-6, IL-8, IL-10, granulocyte-macrophage colony-stimulating-factor [GM-CSF], interferon [IFN-γ], tumor necrosis factor [TNF-α]) using a multiplex assay...
2024: Inquiry: a Journal of Medical Care Organization, Provision and Financing
https://read.qxmd.com/read/38641978/prevalence-of-pre-hypertension-hypertension-and-its-associated-factors-among-adults-in-the-wolaita-zone-of-southern-ethiopia-a-cross-sectional-study
#24
JOURNAL ARTICLE
Eshetu Elfios Endrias, Teketel Tesfaye Mamito, Temesgen Geta Hardido, Bizuayehu Atinafu Ataro
Preventing the development of high blood pressure and resulting complication requires estimating the prevalence of prehypertension/hypertension and identifying associated risk factors. Information about pre-hypertension/hypertension in Ethiopia, especially in the southern region, is scarce, and limited knowledge exists regarding the prevalence and risk factors associated with pre-hypertension/hypertension. Objective of this study was to assess prevalence of pre-hypertension/hypertension and its associated factors among adults in Wolaita Zone of Southern Ethiopia, 2023...
2024: Inquiry: a Journal of Medical Care Organization, Provision and Financing
https://read.qxmd.com/read/38641966/glucose-color-index-development-and-validation-of-a-novel-measure-of-the-shape-of-glycemic-variability
#25
JOURNAL ARTICLE
Joseph Sartini, Michael Fang, Mary R Rooney, Elizabeth Selvin, Josef Coresh, Scott Zeger
BACKGROUND: Standard continuous glucose monitoring (CGM) metrics: mean glucose, standard deviation, coefficient of variation, and time in range, fail to capture the shape of variability in the CGM time series. This information could facilitate improved diabetes management. METHODS: We analyzed CGM data from 141 adults with type 2 diabetes in the Hyperglycemic Profiles in Obstructive Sleep Apnea (HYPNOS) trial. Participants in HYPNOS wore CGM sensors for up to two weeks at two time points, three months apart...
April 20, 2024: Journal of Diabetes Science and Technology
https://read.qxmd.com/read/38641003/experiences-of-motivational-interviewing-in-virtual-healthcare-visits-for-adults-with-type-2-diabetes-mellitus-a-qualitative-analysis
#26
JOURNAL ARTICLE
Kimberley Lau, Carlos Escudero, Irene Lee, Catherine Yu
AIMS: The purpose of this qualitative study is to identify barriers minimizing the effectiveness of motivational interviewing during virtual clinic encounters for individuals with type 2 diabetes based on the Capability, Opportunity, Motivation-Behaviour (COM-B) model. METHODS: One-on-one semi-structured interviews were conducted from March to June 2023 with 17 adults with type 2 diabetes (64.7% female, median age 69 years with age range 47-83 years) followed at St...
April 17, 2024: Canadian Journal of Diabetes
https://read.qxmd.com/read/38640616/management-of-uncomplicated-appendicitis-in-adults-a-nationwide-analysis-from-2018-to-2019
#27
JOURNAL ARTICLE
Maria Korah, Lakshika Tennakoon, Lisa M Knowlton, Jamie Tung, David A Spain, Ara Ko
INTRODUCTION: Nonoperative management (NOM) of uncomplicated appendicitis (UA) has been increasingly utilized in recent years. The aim of this study was to describe nationwide trends of sociodemographic characteristics, outcomes, and costs of patients undergoing medical versus surgical management for UA. METHODS: The 2018-2019 National (Nationwide) Inpatient Sample was queried for adults (age ≥18 y) with UA; diagnosis, as well as laparoscopic and open appendectomy, were defined by the International Classification of Diseases, 10th Revision, Clinical Modification codes...
April 18, 2024: Journal of Surgical Research
https://read.qxmd.com/read/38640133/the-impact-of-obesity-induced-inflammation-on-clonal-hematopoiesis
#28
JOURNAL ARTICLE
Santhosh Kumar Pasupuleti, Reuben Kapur
PURPOSE OF REVIEW: This review meticulously delves into existing literature and recent findings to elucidate the intricate link between obesity and clonal hematopoiesis of indeterminate potential (CHIP) associated clonal hematopoiesis. It aims to enhance our comprehension of this multifaceted association, offering insights into potential avenues for future research and therapeutic interventions. RECENT FINDINGS: Recent insights reveal that mutations in CHIP-associated genes are not limited to symptomatic patients but are also present in asymptomatic individuals...
April 22, 2024: Current Opinion in Hematology
https://read.qxmd.com/read/38639876/continuous-glucose-monitoring-with-structured-education-in-adults-with-type-2-diabetes-managed-by-multiple-daily-insulin-injections-a-multicentre-randomised-controlled-trial
#29
JOURNAL ARTICLE
Ji Yoon Kim, Sang-Man Jin, Kang Hee Sim, Bo-Yeon Kim, Jae Hyoung Cho, Jun Sung Moon, Soo Lim, Eun Seok Kang, Cheol-Young Park, Sin Gon Kim, Jae Hyeon Kim
AIMS/HYPOTHESIS: The aim of this study was to compare the effectiveness of stand-alone intermittently scanned continuous glucose monitoring (isCGM) with or without a structured education programme and blood glucose monitoring (BGM) in adults with type 2 diabetes on multiple daily insulin injections (MDI). METHODS: In this 24 week randomised open-label multicentre trial, adults with type 2 diabetes on intensive insulin therapy with HbA1c levels of 58-108 mmol/mol (7...
April 19, 2024: Diabetologia
https://read.qxmd.com/read/38639706/incident-functional-limitations-among-older-adults-with-diabetes-during-the-covid-19-pandemic-an-analysis-of-prospective-data-from-the-canadian-longitudinal-study-on-aging
#30
JOURNAL ARTICLE
Andie MacNeil, Susanna Abraham Cottagiri, Paul J Villeneuve, Ying Jiang, Margaret de Groh, Esme Fuller-Thomson
OBJECTIVES: The objectives of this study were: 1) to examine and compare changes in functional limitations during the COVID-19 pandemic among older adults with and without diabetes; and 2): to identify key risk factors associated with developing functional limitations among older adults with and without diabetes during the pandemic. METHODS: We analyzed data collected from the Canadian Longitudinal Study on Aging. The analysis was restricted to those with no functional limitations in the follow-up 1 wave (2015 to 2018) (final sample N=6,045)...
April 12, 2024: Canadian Journal of Diabetes
https://read.qxmd.com/read/38639648/the-effect-of-physical-activity-on-cytokine-levels-in-adults-living-with-type-1-diabetes-a-preliminary-study
#31
JOURNAL ARTICLE
Małgorzata Kowal, Renata Woźniacka, Anna Ścisłowska-Czarnecka, Joanna Homa, Wojciech Głodzik
The aim of this study is to investigate whether physical activity and the level of body fat are factors reducing the level of pro-inflammatory cytokines in people with T1DM. Twenty-five men (27.8 ± 9.4 years old; 178.9 ± 6.9 cm; 80.6 ± 12 kg) and 18 women (28.1 ± 12.5 years old; 162.4 ± 5.5; 63.1 ± 9.9 kg) were divided into four groups based on body fat percentage and level of physical activity (AN-active people with normal body fat; IAN-inactive people with normal body fat; AO-active people with excessive body fat, IAO-inactive people with excessive body fat)...
April 2024: Physiological Reports
https://read.qxmd.com/read/38639549/newer-pharmacologic-treatments-in-adults-with-type-2-diabetes-a-systematic-review-and-network-meta-analysis-for-the-american-college-of-physicians
#32
REVIEW
Tyler Drake, Adrienne Landsteiner, Lisa Langsetmo, Roderick MacDonald, Maylen Anthony, Caleb Kalinowski, Kristen Ullman, Charles J Billington, Anjum Kaka, Shahnaz Sultan, Timothy J Wilt
BACKGROUND: Newer diabetes medications may have beneficial effects on mortality, cardiovascular outcomes, and renal outcomes. PURPOSE: To evaluate the effectiveness, comparative effectiveness, and harms of sodium-glucose cotransporter-2 (SGLT2) inhibitors, glucagon-like peptide-1 (GLP1) agonists, dipeptidyl peptidase-4 (DPP4) inhibitors, and long-acting insulins as monotherapy or combination therapy in adults with type 2 diabetes mellitus (T2DM). DATA SOURCES: MEDLINE and EMBASE for randomized controlled trials (RCTs) published from 2010 through January 2023...
April 19, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38639547/cost-effectiveness-of-newer-pharmacologic-treatments-in-adults-with-type-2-diabetes-a-systematic-review-of-cost-effectiveness-studies-for-the-american-college-of-physicians
#33
REVIEW
John T Schousboe, Adrienne Landsteiner, Tyler Drake, Shahnaz Sultan, Lisa Langsetmo, Anjum Kaka, Maylen Anthony, Charles J Billington, Caleb Kalinowski, Kristen Ullman, Timothy J Wilt
BACKGROUND: In the United States, costs of antidiabetes medications exceed $327 billion. PURPOSE: To systematically review cost-effectiveness analyses (CEAs) of newer antidiabetes medications for type 2 diabetes. DATA SOURCES: Bibliographic databases from 1 January 2010 through 13 July 2023, limited to English. STUDY SELECTION: Nonindustry-funded CEAs, done from a U.S. perspective that estimated cost per quality-adjusted life-year (QALY) gained for newer antidiabetic medications...
April 19, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38639546/newer-pharmacologic-treatments-in-adults-with-type-2-diabetes-a-clinical-guideline-from-the-american-college-of-physicians
#34
JOURNAL ARTICLE
Amir Qaseem, Adam J Obley, Tatyana Shamliyan, Lauri A Hicks, Curtis S Harrod, Carolyn J Crandall
DESCRIPTION: The American College of Physicians (ACP) developed this clinical guideline to update recommendations on newer pharmacologic treatments of type 2 diabetes. This clinical guideline is based on the best available evidence for effectiveness, comparative benefits and harms, consideration of patients' values and preferences, and costs. METHODS: This clinical guideline is based on a systematic review of the effectiveness and harms of newer pharmacologic treatments of type 2 diabetes, including glucagon-like peptide-1 (GLP-1) agonists, a GLP-1 agonist and glucose-dependent insulinotropic polypeptide agonist, sodium-glucose cotransporter-2 (SGLT-2) inhibitors, dipeptidyl peptidase-4 (DPP-4) inhibitors, and long-acting insulins, used either as monotherapy or in combination with other medications...
April 19, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38639544/pharmacologic-treatments-in-adults-with-type-2-diabetes-cost-effectiveness-and-comorbidity-considerations
#35
JOURNAL ARTICLE
Fatima Z Syed
No abstract text is available yet for this article.
April 19, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38639543/annals-video-summary-newer-pharmacologic-treatments-in-adults-with-type-2-diabetes
#36
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 19, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38639542/effect-of-isocaloric-time-restricted-eating-on-body-weight-in-adults-with-obesity-a-randomized-controlled-trial
#37
JOURNAL ARTICLE
Nisa M Maruthur, Scott J Pilla, Karen White, Beiwen Wu, May Thu Thu Maw, Daisy Duan, Ruth-Alma Turkson-Ocran, Di Zhao, Jeanne Charleston, Courtney M Peterson, Ryan J Dougherty, Jennifer A Schrack, Lawrence J Appel, Eliseo Guallar, Jeanne M Clark
BACKGROUND: Time-restricted eating (TRE) lowers body weight in many studies. Whether TRE induces weight loss independent of reductions in calorie intake, as seen in rodent studies, is unknown. OBJECTIVE: To determine the effect of TRE versus a usual eating pattern (UEP) on body weight in the setting of stable caloric intake. DESIGN: Randomized, isocaloric feeding study. (ClinicalTrials.gov: NCT03527368). SETTING: Clinical research unit...
April 19, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38639540/visual-guideline-newer-pharmacologic-treatments-in-adults-with-type-2-diabetes-a-visual-clinical-guideline-from-the-american-college-of-physicians
#38
JOURNAL ARTICLE
(no author information available yet)
The purpose of this visual clinical guideline is to provide a visual summary of ACP's clinical guideline, "Newer Pharmacologic Treatments in Adults With Type 2 Diabetes." In addition, this visual clinical guideline features an interactive data visualization of findings associated with ACP's clinical recommendations for this topic.
April 19, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38639366/trends-and-disparities-in-treatment-and-control-of-atherosclerotic-cardiovascular-disease-in-us-adults-1999-to-2018
#39
JOURNAL ARTICLE
Jingen Li, Jie Zhang, Virend K Somers, Naima Covassin, Lijing Zhang, Hao Xu
BACKGROUND: Although cardiovascular mortality continued declining from 2000 to 2019, the rate of this decrease decelerated. We aimed to assess the trends and disparities in risk factor control and treatment among US adults with atherosclerotic cardiovascular disease to find potential causes of the deceleration. METHODS AND RESULTS: A total of 55 ,021 participants, aged ≥20 years, from the 1999 to 2018 National Health and Nutrition Examination Survey were included, of which 5717 were with atherosclerotic cardiovascular disease...
April 19, 2024: Journal of the American Heart Association
https://read.qxmd.com/read/38639364/association-between-hemoglobin-a1c-and-development-of-cardiovascular-disease-in-canadian-men-and-women%C3%A2-without-diabetes-at-baseline-a-population-based-study-of-608%C3%A2-474-adults
#40
JOURNAL ARTICLE
Sonia Butalia, Luan Manh Chu, Douglas C Dover, Darren Lau, Roseanne O Yeung, Dean T Eurich, Peter Senior, Padma Kaul
BACKGROUND: We examined the association between hemoglobin A1c (HbA1c) and the development of cardiovascular disease (CVD) in men and women, without diabetes or CVD at baseline. METHODS AND RESULTS: This retrospective cohort study included adults aged 40 to <80 years in Alberta, Canada. Men and women were divided into categories based on a random HbA1c during a 3-year enrollment period. The primary outcome of CVD hospitalization and secondary outcome of combined CVD hospitalization/mortality were examined during a 5-year follow-up period until March 31, 2021...
April 19, 2024: Journal of the American Heart Association
keyword
keyword
159395
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.